ParkCity Medical Centre provides Cholangiocarcinoma (Bile Duct Cancer) Treatment using contemporary hepatobiliary and oncology techniques and evidence-based care. Founded in 2012, the JCI accredited hospital is based in Kuala Lumpur, Malaysia, with 300 beds and services for domestic and international patients.

The treatment approach depends on whether the cancer is intrahepatic, perihilar, or distal bile duct cancer and whether it can be surgically removed. Depending on the diagnosis, treatment may involve liver or bile duct surgery, chemotherapy, radiation, targeted therapy, or immunotherapy. Imaging, pathology, and molecular profiling help guide treatment planning.